CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,926,169 | -9.9% | 2,559,874 | +3.5% | 0.01% | -9.1% |
| Q2 2023 | $33,229,658 | -15.6% | 2,472,410 | +4.1% | 0.01% | -15.4% |
| Q1 2023 | $39,369,035 | +91581.7% | 2,374,508 | +2.9% | 0.01% | 0.0% |
| Q4 2022 | $42,941 | -99.8% | 2,308,705 | +7.7% | 0.01% | +18.2% |
| Q3 2022 | $27,502,000 | +74.9% | 2,143,567 | -4.4% | 0.01% | +83.3% |
| Q2 2022 | $15,721,000 | -11.6% | 2,242,648 | +4.5% | 0.01% | +20.0% |
| Q1 2022 | $17,784,000 | +38.0% | 2,145,254 | +12.7% | 0.01% | +25.0% |
| Q4 2021 | $12,888,000 | +38.7% | 1,903,568 | +8.5% | 0.00% | +33.3% |
| Q3 2021 | $9,294,000 | +10.6% | 1,753,974 | +20.1% | 0.00% | 0.0% |
| Q2 2021 | $8,401,000 | +53.8% | 1,460,941 | +23.1% | 0.00% | +50.0% |
| Q1 2021 | $5,462,000 | +138.4% | 1,186,467 | +73.0% | 0.00% | +100.0% |
| Q4 2020 | $2,291,000 | +12.1% | 685,761 | -0.2% | 0.00% | 0.0% |
| Q3 2020 | $2,043,000 | -31.1% | 687,234 | +7.0% | 0.00% | 0.0% |
| Q2 2020 | $2,967,000 | +41.1% | 642,230 | +17.5% | 0.00% | 0.0% |
| Q1 2020 | $2,103,000 | +33.3% | 546,362 | +29.8% | 0.00% | 0.0% |
| Q4 2019 | $1,578,000 | -26.4% | 421,020 | +4.2% | 0.00% | 0.0% |
| Q3 2019 | $2,145,000 | +38.3% | 404,030 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,551,000 | -25.3% | 404,030 | -0.8% | 0.00% | 0.0% |
| Q1 2019 | $2,077,000 | +161.3% | 407,230 | -1.5% | 0.00% | – |
| Q4 2018 | $795,000 | -19.7% | 413,520 | +58.0% | 0.00% | – |
| Q3 2018 | $990,000 | +392.5% | 261,782 | +463.7% | 0.00% | – |
| Q1 2015 | $201,000 | +45.7% | 46,438 | 0.0% | 0.00% | – |
| Q4 2014 | $138,000 | -10.4% | 46,438 | 0.0% | 0.00% | – |
| Q3 2014 | $154,000 | +31.6% | 46,438 | 0.0% | 0.00% | – |
| Q2 2014 | $117,000 | +11.4% | 46,438 | 0.0% | 0.00% | – |
| Q1 2014 | $105,000 | +15.4% | 46,438 | 0.0% | 0.00% | – |
| Q4 2013 | $91,000 | -35.9% | 46,438 | 0.0% | 0.00% | – |
| Q3 2013 | $142,000 | +246.3% | 46,438 | 0.0% | 0.00% | – |
| Q2 2013 | $41,000 | – | 46,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |